Role of biochemical markers in assessment of osteoporosis

Acta Orthopaedica

Volumn 66, Issue S266, 1995, Pages 14-18

  Riggs, B Lawrence ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; OSTEOCALCIN; ACID PHOSPHATASE; ALENDRONIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; CALCIUM; PROCOLLAGEN; PYRIDINIUM DERIVATIVE;

BLOOD; BONE DENSITY; FEMALE; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR; URINE; BONE MINERAL; BONE TURNOVER; CROSS LINKING; DENSITOMETRY; ESTROGEN THERAPY; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PATIENT SELECTION; SHORT SURVEY;

ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; DIPHOSPHONATES; ESTROGENS; FEMALE; HUMANS; OSTEOCALCIN; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 0029560020     PISSN: 17453674     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679509157640     Document Type: Article

References (24)

1. Short-term intraindividual variability of markers of bon turnover in healthy adults
2. Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment
3. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women: implications for the mechanism of age-related bone loss
4. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein
5. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis
6. Biochemical markers for the assessment of bone turnover: Clinical use in osteoporosis
7. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease
8. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing
9. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption
10. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis
11. Comparison of new biochemicalmarkers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
12. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine
13. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study
14. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age
15. Treatment of postmenopausal osteoporosis with transdermal estrogen
16. Impact of high bone turnover on bone loss and fractures in the elderly
17. Impaired osteoblast function in metabolic bone disease
18. Evidence for two distinct syndromes of involutional osteoporosis
19. Calcitriol in the treatment of osteoporosis
20. The worldwide problem of osteoporosis: insights afforded by epidemiology
21. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation
22. Histologic-morphometric studies of old age atrophy and senile osteoporosis in the crest of ilium
23. Immunoassay for urinary pyridinoline: the new marker of bone resorption
24. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links